Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gametocyte surface protein P230 (Pfs230) is a large, cysteine-rich peripheral membrane protein belonging to the 6-cysteine (6-cys) family in Plasmodium falciparum. It is expressed on the surface of gametocytes and gametes, where it forms a complex with the glycosylphosphatidylinositol (GPI)-anchored protein Pfs48/45. Pfs230 plays a critical role in the sexual reproduction stage of the malaria parasite, specifically mediating male gamete exflagellation, interaction with host erythrocytes, and male-female gamete fusion during fertilization in the mosquito midgut. Because of its essential role in parasite transmission, Pfs230 is a leading target for malaria transmission-blocking vaccines (TBVs). Vaccines such as Pfs230D1-EPA and multi-stage candidates like ProC6C aim to elicit high titers of transmission-blocking antibodies in the human host. When a mosquito ingests these antibodies during a blood meal, they bind to Pfs230 on the gamete surface and, in a complement-dependent manner, inhibit fertilization and subsequent oocyst development, thereby halting the transmission cycle of malaria.
Active immunization with Pfs230-based vaccines elicits host antibodies that are ingested by mosquitoes during a blood meal. These antibodies, along with host complement, bind to Pfs230 on the surface of gametes in the mosquito midgut, blocking gamete fusion, fertilization, and subsequent development into oocysts, thereby preventing malaria transmission. Passive administration of monoclonal antibodies like LMIV230-01 similarly blocks transmission by targeting conserved epitopes on Pfs230.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gametocyte surface protein P230 (Pfs230).